Biography
Research Topics
Research
Summary of Research
A major portion of our work aims to discover novel treatments to improve function after paralysis from a spinal cord injury. Other major projects currently being investigated in our lab are:
- Delineating the cellular and molecular roles of Numb and Numb-like in skeletal muscle function.
- Understanding the cellular and molecular basis for the worse outcomes of persons with SCI carrying ApoE4 as compared to ApoE3.
- Testing the role ryanodine receptor dysfunction in skeletal muscle after spinal cord injury and underlying biochemical and molecular mechanisms.
- Systematic studies of the integrative physiology responsible for altered metabolomic profile after spinal cord injury.
Research Interests
Improving muscle function in older adults and after spinal cord injury. Understanding the impact of common genetic variants on function and pain after spinal cord injury Development of pharmaceuticals to improve physical and metabolic function in immobilized populationsEducation
MD, University Wisconsin
The Mount Sinai Hospital
Mount Sinai School of Medicine
The Mount Sinai Hospital
BS, University of Wisconsin
Office Locations
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Cardozo has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Cardozo has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.